Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer

Jamboor K. Vishwanatha, Ryan Swinney, Abhijit G. Banerjee

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Smokeless tobacco usage is a growing public health concern in the United States. Epidemiological evidence shows a correlation between use of chewing tobacco, lesions of the oral cavity and the incidence of oral and other cancers. However, the molecular mechanism(s) underlying the oral cancer causation are yet unknown. The major constituents of tobacco are known to cause inflammation, DNA damage and cell death. We propose modulation of inflammatory mediators by smokeless tobacco as a novel mechanism for the development of oral cancer. Exposure of hamster cheek pouches to smokeless tobacco extract (STE) results in cleavage of the anti-inflammatory peptide from the anti-inflammatory protein annexin I. Annexin I is produced from cultured oral epithelial cells and its expression is modulated by STE. We further show that STE exposure of oral epithelial cells results in upregulation of the pro-inflammatory protein COX-2. COX-2 is also upregulated in immortalized human oral epithelial cells, human squamous cell carcinoma cells and in primary tumor tissues from head and neck cancer. In summary, we find that exposure to smokeless tobacco results in loss of the anti-inflammatory activity of annexin I and upregulation of the pro-inflammatory COX-2 in oral cells. The dual effect of these regulatory events leads the cells down the carcinogenic pathway.

Original languageEnglish
Pages (from-to)67-75
Number of pages9
JournalMolecular and Cellular Biochemistry
Volume248
Issue number1-2
DOIs
StatePublished - 1 Jun 2003

Fingerprint

Annexin A1
Smokeless Tobacco
Mouth Neoplasms
Cyclooxygenase 2
Modulation
Inflammation
Anti-Inflammatory Agents
Epithelial Cells
Up-Regulation
Tobacco
Cheek
Public health
Cell death
Head and Neck Neoplasms
Cricetinae
Causality
DNA Damage
Mouth
Tumors
Squamous Cell Carcinoma

Keywords

  • Annexin
  • Cyclooxygenase
  • Inflammation
  • Oral cancer
  • Smokeless tobacco

Cite this

@article{eed8ef5281d84cc98384f7c03e60d61b,
title = "Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer",
abstract = "Smokeless tobacco usage is a growing public health concern in the United States. Epidemiological evidence shows a correlation between use of chewing tobacco, lesions of the oral cavity and the incidence of oral and other cancers. However, the molecular mechanism(s) underlying the oral cancer causation are yet unknown. The major constituents of tobacco are known to cause inflammation, DNA damage and cell death. We propose modulation of inflammatory mediators by smokeless tobacco as a novel mechanism for the development of oral cancer. Exposure of hamster cheek pouches to smokeless tobacco extract (STE) results in cleavage of the anti-inflammatory peptide from the anti-inflammatory protein annexin I. Annexin I is produced from cultured oral epithelial cells and its expression is modulated by STE. We further show that STE exposure of oral epithelial cells results in upregulation of the pro-inflammatory protein COX-2. COX-2 is also upregulated in immortalized human oral epithelial cells, human squamous cell carcinoma cells and in primary tumor tissues from head and neck cancer. In summary, we find that exposure to smokeless tobacco results in loss of the anti-inflammatory activity of annexin I and upregulation of the pro-inflammatory COX-2 in oral cells. The dual effect of these regulatory events leads the cells down the carcinogenic pathway.",
keywords = "Annexin, Cyclooxygenase, Inflammation, Oral cancer, Smokeless tobacco",
author = "Vishwanatha, {Jamboor K.} and Ryan Swinney and Banerjee, {Abhijit G.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1023/A:1024153431272",
language = "English",
volume = "248",
pages = "67--75",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer. / Vishwanatha, Jamboor K.; Swinney, Ryan; Banerjee, Abhijit G.

In: Molecular and Cellular Biochemistry, Vol. 248, No. 1-2, 01.06.2003, p. 67-75.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer

AU - Vishwanatha, Jamboor K.

AU - Swinney, Ryan

AU - Banerjee, Abhijit G.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Smokeless tobacco usage is a growing public health concern in the United States. Epidemiological evidence shows a correlation between use of chewing tobacco, lesions of the oral cavity and the incidence of oral and other cancers. However, the molecular mechanism(s) underlying the oral cancer causation are yet unknown. The major constituents of tobacco are known to cause inflammation, DNA damage and cell death. We propose modulation of inflammatory mediators by smokeless tobacco as a novel mechanism for the development of oral cancer. Exposure of hamster cheek pouches to smokeless tobacco extract (STE) results in cleavage of the anti-inflammatory peptide from the anti-inflammatory protein annexin I. Annexin I is produced from cultured oral epithelial cells and its expression is modulated by STE. We further show that STE exposure of oral epithelial cells results in upregulation of the pro-inflammatory protein COX-2. COX-2 is also upregulated in immortalized human oral epithelial cells, human squamous cell carcinoma cells and in primary tumor tissues from head and neck cancer. In summary, we find that exposure to smokeless tobacco results in loss of the anti-inflammatory activity of annexin I and upregulation of the pro-inflammatory COX-2 in oral cells. The dual effect of these regulatory events leads the cells down the carcinogenic pathway.

AB - Smokeless tobacco usage is a growing public health concern in the United States. Epidemiological evidence shows a correlation between use of chewing tobacco, lesions of the oral cavity and the incidence of oral and other cancers. However, the molecular mechanism(s) underlying the oral cancer causation are yet unknown. The major constituents of tobacco are known to cause inflammation, DNA damage and cell death. We propose modulation of inflammatory mediators by smokeless tobacco as a novel mechanism for the development of oral cancer. Exposure of hamster cheek pouches to smokeless tobacco extract (STE) results in cleavage of the anti-inflammatory peptide from the anti-inflammatory protein annexin I. Annexin I is produced from cultured oral epithelial cells and its expression is modulated by STE. We further show that STE exposure of oral epithelial cells results in upregulation of the pro-inflammatory protein COX-2. COX-2 is also upregulated in immortalized human oral epithelial cells, human squamous cell carcinoma cells and in primary tumor tissues from head and neck cancer. In summary, we find that exposure to smokeless tobacco results in loss of the anti-inflammatory activity of annexin I and upregulation of the pro-inflammatory COX-2 in oral cells. The dual effect of these regulatory events leads the cells down the carcinogenic pathway.

KW - Annexin

KW - Cyclooxygenase

KW - Inflammation

KW - Oral cancer

KW - Smokeless tobacco

UR - http://www.scopus.com/inward/record.url?scp=0038642503&partnerID=8YFLogxK

U2 - 10.1023/A:1024153431272

DO - 10.1023/A:1024153431272

M3 - Article

C2 - 12870656

AN - SCOPUS:0038642503

VL - 248

SP - 67

EP - 75

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -